Related Experiment Video
Updated: Sep 5, 2025

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Infections With Stenotrophomonas maltophilia in Children Undergoing Anticancer Therapy or Hematopoietic Cell
Monika Richert-Przygonska1, Krzysztof Czyzewski1, Magdalena Dziedzic1
1From the Department of Pediatrics, Hematology and Oncology.
Insights
Stenotrophomonas maltophilia infections are a serious risk for children with cancer or those undergoing stem cell transplants. While treatment options exist, outcomes are significantly worse for transplant patients, highlighting a critical need for improved strategies.
Area of Science:
- Pediatric Hematology and Oncology
- Infectious Diseases
- Transplantation Immunology
Background:
- Infections caused by Stenotrophomonas maltophilia (SM) are associated with high mortality rates in immunocompromised individuals.
- Pediatric patients undergoing anticancer therapy or hematopoietic cell transplantation (HCT) are particularly vulnerable to SM infections.
Purpose of the Study:
- To analyze the epidemiology of SM infections in children undergoing anticancer therapy (pediatric hematology and oncology [PHO]) or HCT between 2012-2019.
- To determine the incidence, outcomes, treatment regimens, and multidrug resistance patterns of SM infections in these pediatric populations.
Main Methods:
- A nationwide multicenter study analyzing 1356 HCTs and 7337 newly diagnosed malignancy cases in children.
- Cumulative incidence calculated using competing risk analysis; survival determined by the Kaplan-Meier method.
- Analysis included diagnosis of acute leukemia as a predisposing factor and antibiotic susceptibility testing.
Main Results:
- The cumulative incidence of SM infections was similar in HCT and PHO patients (0.81% vs. 0.76%).
- High susceptibility to trimethoprim/sulfamethoxazole (80.8%) was observed, yet survival rates were significantly lower in HCT patients (45%) compared to PHO patients (85%).
- The transplant procedure and lack of clinical resolution after 18 days of antibiotics were independent mortality risk factors.
Conclusions:
- The risk of SM infections and resistant strains in allogeneic HCT patients is comparable to PHO patients.
- Despite similar infection risks and antibiotic susceptibility, outcomes for SM infections are poorer in the HCT setting compared to the PHO setting.
Background:
Infections caused by Stenotrophomonas maltophilia (SM) have documented high mortality rate in immunocompromised patients.
Aim:
This nationwide multicenter study was performed to analyze the epidemiology of SM infections in children undergoing anticancer therapy (pediatric hematology and oncology [PHO]) or hematopoietic cell transplantation (HCT) over 2012-2019, including incidence and outcome of SM infections, as well as treatment regimens and multidrug resistance.
Methods:
Cumulative incidence of SM infections was calculated using the competing risk analysis from the day of diagnosis (PHO setting) or from the day of transplantation (HCT setting). The Kaplan-Meier method was used to determine survival from infection.
Results:
During the study period of 8 years, a total number of 1356 HCTs and 7337 children newly diagnosed for malignancy were analyzed. Diagnosis of acute leukemia was a predisposing factor for SM infection. The cumulative incidence of SM infections was comparable in HCT patients in comparison to PHO (0.81% vs. 0.76%). High rate of trimethoprim/sulfamethoxazole susceptibility among SM isolates was observed in both groups of patients (80.8%). Although this was the drug of choice, survival rates from SM infections were significantly lower in HCT than in PHO (45% vs. 85%, P = 0.001, log-rank test). We found the transplant procedure and lack of clinical resolution after 18 days of antibiotic therapy to be independent mortality risk factors.
Conclusions:
The risk of SM infections and the occurrence of resistant bacterial strains in allo-HCT patients were comparable to PHO patients. Irrespective of target antibiotic therapy, the outcome of SM infections was better in the PHO setting.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

